Dr. Muhammad Furqan is a medical oncologist at the University of Iowa’s Holden Comprehensive Cancer Center. As a specialist in lung cancer treatment and research, he has been named Interim Associate Director of Clinical Research and also serves as a Clinical Associate Professor of Internal Medicine-Hematology, Oncology, and Blood & Marrow Transplantation at the Carver
Dr. Chad E. Denlinger is a thoracic surgeon at Indiana University Health in Indianapolis and a tenured Professor of Surgery at Indiana University School of Medicine. An expert in diseases of the chest, his clinical interests include the treatment of lung cancers and esophageal cancers, advanced lung disease, lung transplant, gastroesophageal reflux disease, cardiothoracic surgery,
Dr. Nasser H. Hanna is a specialist in internal medicine with a focus on thoracic oncology. He is the Associate Division Director of the Department of Oncology, as well as the Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research and a Professor of Medicine in the Division of Hematology/Oncology at the
As a pulmonologist and critical care specialist, Dr. Francis D. Sheski is an invaluable member of Indiana University’s Melvin and Bren Simon Comprehensive Cancer Center and the Indiana University School of Medicine in Indianapolis, Indiana. His clinical interests include interventional pulmonology for lung cancer and pleural diseases, and he specializes in bronchoscopy and thoracoscopy. Dr.
Dr. Darren Bryan is a thoracic surgeon who has dedicated himself to caring for patients with lung cancer and malignant pleural mesothelioma. As a thoracic surgeon, he is a member of the University of Chicago Comprehensive Cancer Center’s mesothelioma treatment team, using his skills in both traditional and minimally invasive/robotic surgical techniques to provide the
Dr. Mark Ferguson is a thoracic and cardiac surgeon in the Department of Surgery at the University of Chicago Comprehensive Cancer Center. His surgical specialty is the management of lung, esophageal, and thymus diseases. He is experienced in all techniques of lung and esophageal resection, as well as the management of malignant pleural effusions. Dr.
Dr. Jessica S. Donington is a thoracic surgeon and clinical researcher whose particular interests and skills are the treatment of lung, esophageal, and mediastinal conditions. As Chief of the University of Chicago’s Department of Surgery’s Thoracic Surgery section, she specializes in the multidisciplinary care of both benign and malignant chest diseases, including lung cancer and
Dr. Ankit Bharat is a board-certified thoracic surgeon and general surgeon whose clinical focus is on the treatment of malignant and benign chest diseases, including lung cancer and malignant pleural mesothelioma. He is the Chief of Thoracic Surgery at Lurie Cancer Center and Northwestern Medicine, as well as the Harold L. and Margaret N. Method
A follow-up survey conducted by the National Comprehensive Cancer Network (NCCN) has revealed that though shortages of chemotherapy drugs are continuing, they are having little to no impact on mesothelioma patients and others diagnosed with other cancers. Experts attribute this to the adoption of strict protocols and strategies regarding the use of available resources. Chemotherapy Drug Shortages
The International Association for the Study of Lung Cancer held its 2023 World Conference on Lung Cancer last week, and much of the information presented focused on discoveries in malignant mesothelioma. One clinical trial’s results were presented focused on the importance of dendritic cells and how they can be leveraged to stimulate immune responses.